Physician profile
Katie Flower
NPI 1013398650
$3,806.53
in general payments reported to CMS, 2019-2025
29 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,448 · 2020: $86.67 · 2021: $303 · 2022: $261 · 2023: $169 · 2024: $392 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,428.18 | 2019-2025 | Rezum Generator, Moses 550 Dfl, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $218.34 | 2019-2024 | Xtandi |
| Sumitomo Pharma America, INC. | $152.04 | 2023-2025 | Orgovyx, Gemtesa |
| Endo Pharmaceuticals INC. | $143.98 | 2019-2022 | |
| Abbvie INC. | $81.89 | 2022-2024 | |
| Urovant Sciences INC | $69.51 | 2022 | |
| Axonics, INC. | $68.82 | 2021-2024 | Axonics |
| Myovant Sciences INC. | $57.00 | 2021-2022 | |
| Janssen Biotech, INC. | $56.21 | 2021-2025 | Erleada |
| Photocure INC | $55.59 | 2021-2023 | Cysview |
| Hollister Incorporated | $48.83 | 2021-2023 | Infyna Chic |
| Coloplast Corp | $40.34 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $38.71 | 2024 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Teleflex LLC | $36.76 | 2021-2024 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $32.96 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $28.91 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $28.60 | 2021 | |
| Neotract INC. | $26.20 | 2020 | |
| Antares Pharma, INC. | $23.41 | 2021 | |
| Tolmar, INC. | $22.69 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $21.30 | 2023 | Seglentis |
| Karl Storz Endoscopy-America | $20.15 | 2021 | |
| Olympus America INC. | $19.64 | 2024 | Itind System |
| Acerus Pharmaceuticals Corporation | $18.30 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $16.14 | 2020 | |
| Clarus Therapeutics INC. | $15.52 | 2021 | |
| Smith+Nephew, INC. | $14.40 | 2022 | |
| Medtronic USA, INC. | $11.06 | 2020 | |
| Cook Medical LLC | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Flower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.